Your session is about to expire
← Back to Search
Strategies to Reduce Preoperative Benzodiazepine Use in Aging Surgical Patients (DROP-Benzo Trial)
N/A
Waitlist Available
Led By Mark D Neuman, MD, MSc
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 30 days after surgery
Awards & highlights
DROP-Benzo Trial Summary
This trial will test whether peer comparison feedback or mailed informational letters to patients can help reduce the number of older surgical patients in the US who receive benzodiazepines during anesthesia care.
Who is the study for?
This trial is for anesthesia clinicians at USAP and patients aged 65 or older undergoing scheduled surgery under general anesthesia. It excludes urgent/emergent cases, those receiving nerve blocks, or not under general anesthesia.Check my eligibility
What is being tested?
The study tests if peer feedback to clinicians and informational letters to patients can reduce the use of preoperative benzodiazepines in older surgical patients, which may be unnecessary and risky.See study design
What are the potential side effects?
Since this trial focuses on reducing medication rather than administering it, there are no direct side effects from interventions being tested. However, usual risks associated with surgery still apply.
DROP-Benzo Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 30 days after surgery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 30 days after surgery
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Benzodiazepine administration rate
Secondary outcome measures
Patient satisfaction
Other outcome measures
Hospital length of stay
Postoperative Delirium
Postoperative pulmonary complications
DROP-Benzo Trial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: Peer Comparison Feedback plus Patient Informational LetterExperimental Treatment2 Interventions
Group II: Peer Comparison FeedbackExperimental Treatment1 Intervention
Group III: Patient Informational LetterExperimental Treatment1 Intervention
Group IV: ControlActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Patient Informational Letter
2022
N/A
~517620
Peer Comparison Feedback
2022
N/A
~517620
Find a Location
Who is running the clinical trial?
University of PennsylvaniaLead Sponsor
2,000 Previous Clinical Trials
42,362,477 Total Patients Enrolled
8 Trials studying Surgery
28,224 Patients Enrolled for Surgery
US Anesthesia PartnersUNKNOWN
Donaghue Medical Research FoundationOTHER
23 Previous Clinical Trials
60,856 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You had a procedure called a nerve block.You must have received general anesthesia.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Peer Comparison Feedback
- Group 3: Patient Informational Letter
- Group 4: Peer Comparison Feedback plus Patient Informational Letter
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this research endeavor currently have openings for participants?
"Affirmative. On clinicaltrials.gov, it is evident that this trial began recruiting on August 8th 2022 and has recently been updated as of August 22nd 2022. The study requires 225000 patients to be enrolled from a single site."
Answered by AI
How many individuals are being included in this medical research?
"Indeed, the information on clinicaltrials.gov shows that this medical experiment is recruiting. It was first announced on August 8th 2022 and reconfirmed most recently on August 22nd of the same year. The trial seeks to enrol 225000 patients at one location."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger